文献速递脑血管病

可逆性脑血管收缩综合征伴凸面蛛网膜下腔出血的结局:个体患者数据分析

Outcomes After Reversible Cerebral Vasoconstriction Syndrome With Convexity Subarachnoid Hemorrhage: Individual Patient Data Analysis.
PubMed 文献 · Neurology · 2025-08-20

本研究通过系统检索和个体患者数据汇总分析,评估可逆性脑血管收缩综合征(RCVS)相关凸面蛛网膜下腔出血(cSAH)后的长期血管事件、功能结局和死亡率。纳入138例患者,平均随访1.8年,cSAH复发、脑出血和缺血性卒中的年发生率均为0.81%,94.3%的患者功能独立(mRS≤1),年死亡率为0.5%。

要点

  • RCVS相关cSAH后复发血管事件年发生率低,约为0.81%。
  • 大多数患者(94.3%)随访时无显著残疾(mRS≤1)。
  • 年死亡率低(0.5%),死亡多发生在早期。

核心结论

  • RCVS相关cSAH患者总体预后良好,复发事件率低且功能独立比例高。

研究设计与样本

  • 个体患者数据汇总分析,系统检索PubMed和EMBASE,最终纳入9个中心的138例患者。
  • 采用纽卡斯尔-渥太华量表进行质量评估,随访截断至5年。

主要发现

  • 平均随访1.8年,cSAH复发、脑出血和缺血性卒中的年发生率均为0.81%(95%CI 0.1-2.91)。
  • 初始发作期间进展:cSAH 10例,脑出血2例,缺血性卒中8例。
  • 106例(76.8%)有结局数据的患者中,100例(94.3%)达到mRS≤1。
  • 2例死亡,年死亡率0.5%(95%CI 0.09-2.9),分别发生在cSAH后10天内和2个月内。

临床怎么用

  • RCVS相关cSAH患者可预期较好的功能结局,临床咨询时可提供预后信息。
  • 尽管复发率低,仍需关注早期进展和死亡风险。

局限性

  • 回顾性数据收集。
  • 提供个体患者数据的中心可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: The most common cause of convexity subarachnoid hemorrhage (cSAH) in younger patients (younger than 60 years) is reversible cerebral vasoconstriction syndrome (RCVS). Evidence on the long-term outcomes of future vascular events and functional outcome after cSAH due to RCVS is limited. We aimed to assess the rates and baseline predictors of our primary outcomes (cSAH, intracerebral hemorrhage (ICH), and ischemic stroke), functional outcome, and mortality after cSAH attributed to RCVS. METHODS: Individual patient data pooled analysis in patients with cSAH attributed to RCVS. A systematic literature search was conducted in PubMed and EMBASE. Two independent reviewers screened studies and extracted data. Quality assessment was assessed using the Newcastle-Ottawa Scale. Early events during the accepted time frame of an RCVS episode (<3 months) were classified as progression rather than recurrence. Follow-up was truncated at 5 years. Primary outcomes were recurrent cSAH, ICH, and ischemic stroke. Secondary outcomes were mortality and functional status measured by modified Rankin Score (mRS). RESULTS: We identified 21 eligible cohorts finally including 138 patients from 9 collaborative centers, which provided individual patient data. The mean age was 49.3 ± 12.1 years, and 110 (79.7%) were female. During a mean follow-up of 1.8 years, annual rates were cSAH recurrence 0.81% (95% CI 0.1-2.91), ICH 0.81% (95% CI 0.1-2.91), and ischemic stroke 0.81% (95% CI 0.1-2.91). Progression during the initial episode (shortly after admission) occurred in 10 patients for cSAH, 2 for ICH, and 8 for ischemic stroke, respectively. Of 106 patients (76.8%) with available outcome data, 100 (94.3%) achieve a mRS of ≤1 at follow-up, indicating no significant disability. Two patients died (annual rate 0.5%, 95% CI 0.09-2.9): one within 10 days and the other within 2 months of the cSAH. DISCUSSION: Our data suggest a favorable prognosis for most patients after RCVS-associated cSAH with low rates of recurrent events and a high proportion achieving functional independence. Major limitations include retrospective data collection and potential selection bias from centers providing individual patient data. Nevertheless, these findings provide prognostic information to inform clinical practice.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Hostettler IC, Ponciano A, Wilson D, et al. Outcomes After Reversible Cerebral Vasoconstriction Syndrome With Convexity Subarachnoid Hemorrhage: Individual Patient Data Analysis. Neurology. 2025. PMID: 40834342. doi:10.1212/WNL.0000000000213984

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。